ALLR - Allarity Therapeutics, Inc.


1.34
-0.060   -4.478%

Share volume: 92,050
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations: -0.11%

PREVIOUS CLOSE
CHG
CHG%

$1.40
-0.06
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
38%
Profitability 35%
Dept financing 32%
Liquidity 49%
Performance 40%
Company vs Stock growth
vs
Performance
5 Days
-4.29%
1 Month
25.23%
3 Months
11.67%
6 Months
0   0%
1 Year
25.23%
2 Year
-2.90%
Key data
Stock price
$1.34
P/E Ratio 
0.00
DAY RANGE
$1.33 - $1.39
EPS 
-$8.26
52 WEEK RANGE
$0.77 - $2.35
52 WEEK CHANGE
$25.23
MARKET CAP 
24.983 M
YIELD 
N/A
SHARES OUTSTANDING 
15.812 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
1.90
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$165,957
AVERAGE 30 VOLUME 
$133,100
Company detail
CEO: James G. Cullem
Region: US
Website: allarity.com
Employees: 10
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

N/A

Recent news